Skip Navigation


International Immunology Advance Access originally published online on March 31, 2005
International Immunology 2005 17(5):591-597; doi:10.1093/intimm/dxh240
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
17/5/591    most recent
dxh240v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Carralot, J.-P.
Right arrow Articles by Pascolo, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carralot, J.-P.
Right arrow Articles by Pascolo, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Japanese Society for Immunology. 2005. All rights reserved. For permissions, please e-mail: journals.permissions@oupjournals.org

CD8+ T cells specific for a potential HLA-A*0201 epitope from Chlamydophila pneumoniae are present in the PBMCs from infected patients

Jean-Philippe Carralot1,*, Claudia Dumrese2,*, Ralf Wessel3, Reimer Riessen3, Ingo Autenrieth4, Steffen Walter1, Oliver Schoor1, Stefan Stevanovic1, Hans-Georg Rammensee1 and Steve Pascolo1

1 Department of Immunology, Institute for Cell Biology, 3 Department of Medicine III (Cardiology) and 4 Institute for Microbiology, University of Tübingen, Auf der Morgenstelle 15, 72076 Tübingen, Germany
2 Division of Infectious Diseases, University Children's Hospital of Zurich, CH-8032 Zurich, Switzerland

Correspondence to: S. Pascolo; E-mail: steve.pascolo{at}uni-tuebingen.de

Infection with the common pathogen Chlamydophila pneumoniae (Cpn, previously Chlamydia pneumoniae) has a high prevalence in patients suffering from arteriosclerosis and may trigger or contribute to heart disease. In mice, CD8-positive T cells are critical for the eradication of the infection and the development of immune memory against Cpn. Although several H2-class I epitopes have been described, no HLA-class I-associated peptides from Cpn are known. In order to define HLA-A*0201 epitopes from Cpn, we focused on the bacterial heat shock proteins (HSP) 60 and 70 which are known to be recognized by the immune system. Using epitope prediction, peptide binding studies and peptide-specific CTLs from HLA-A2 transgenic mice, we could define a potential HSP-70-derived epitope. The study of PBMCs from Cpn-infected individuals using fluorescent MHC tetramers revealed that some patients have CD8+ T cells capable of recognizing the Cpn HSP-70 HLA-A*0201 epitope. Our studies pave the way to the immunomonitoring of the anti-Cpn CTL immune response present in patients suffering from different diseases potentially linked to Cpn or anti-Cpn immunity.

Keywords: Chlamydophila (Chlamydia) pneumoniae, CTL, epitope, HHD, HSP-70

* These authors contributed equally to this work.

Transmitting editor: S. Kaufmann


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
A. Tvinnereim and B. Wizel
CD8+ T Cell Protective Immunity against Chlamydia pneumoniae Includes an H2-M3-Restricted Response That Is Largely CD4+ T Cell-Independent
J. Immunol., September 15, 2007; 179(6): 3947 - 3957.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. J. Holland, N. Faal, I. Sarr, H. Joof, M. Laye, E. Cameron, F. Pemberton-Pigott, H. M. Dockrell, R. L. Bailey, and D. C. W. Mabey
The Frequency of Chlamydia trachomatis Major Outer Membrane Protein-Specific CD8+ T Lymphocytes in Active Trachoma Is Associated with Current Ocular Infection
Infect. Immun., March 1, 2006; 74(3): 1565 - 1572.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.